Official Recommendations from Novo Nordisk Novo Nordisk, Ozempics maker, has specific advice for its use in patients with gallbladder issues or those who had gallbladder surgery
However, these drugs are associated with a wide array of side effects, and some say alternatives are needed
Unlike brand-name drugs, compounded versions are not FDA-approved as finished products
Epitalon may not be a cancer drug, but it could be part of a future preventive protocol: a peptide that helps keep the cellular script clean before the chaos begins
Anamorelin is the first therapeutic drug in this field and holds the potential to improve the mortality rate and quality of life of cancer patients
Notably, around two-thirds of volume are users new to any GLP-1 therapy, suggesting that convenience, and lower prices expand the market rather than simply driving switching from injectables